14.3 C
New York
Tuesday, March 21, 2023

Is Encompass Health Corporation (NYSE: EHC) The Best Stock To Invest In?

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Encompass Health Corporation (EHC) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$1.08, or -1.77%, to $59.86. The Encompass Health Corporation has recorded 18,438 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Johnston, Rhode Island.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Stocks Info

Encompass Health Corporation is listed on the NYSE in the Healthcare sector while operating in the Medical Care Facilities industry. At the end of the last regular session, the stock closed at $60.94 and fluctuated between $61.68 as its day high and $60.78 as its day low. The current market capitalization of Encompass Health Corporation is $6.12B. A total of 0.56 million shares were traded on the day, compared to an average of 649.47K shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, EHC has seen 1 BUY and 6 SELL insider trades, representing the acquisition of 1,830 and the disposition of 28,218 shares. Over the last 12 months, there were 72 BUYs and 22 SELLs from insiders. Insiders purchased 185,300 shares during that period but sold 77,878.

In the most recent transaction, CARMICHAEL GREG D bought 1,830 shares of EHC for 54.67 per share on Oct 31. After the transaction, the Director now owns 10,546 company shares. In a previous transaction on Aug 17, Tarr Mark J sold 20,449 shares at 53.25 per share. EHC shares that President & CEO owns now total 440,895.

Among the insiders who bought shares, O’Connor Kevin J. acquired of 1,000 shares on May 06 at a per-share price of $66.48. This resulted in the Director holding 3,436 shares of EHC after the transaction.


The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Encompass Health Corporation pays an annual dividend of $0.60, resulting in a dividend yield of 0.98%, and it has a price to earnings (P/E) ratio of 20.97. EHC’s most recent ex-dividend date was 12/30/2022 when it declared a $0.15 quarterly dividend that was paid in cash on 1/17/2023. Previously, the company paid the dividend on 10/17/2022 with an ex-dividend date of 9/30/2022. The EHC stock dividend was $0.15 per share in cash.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for EHC in the last 3 months, the mean price target is $67.11 with high estimates of $72.00 and low estimates of $62.00. In terms of 52-week highs and lows, EHC has a high of $63.27 and a low of $42.16.

As of this writing, EHC has an earnings estimate of $0.82 per share for the current quarter. EPS was calculated based on a consensus of 12 estimates, with a high estimate of $0.91 per share and a lower estimate of $0.29. The company reported an EPS of $0.62 in the last quarter, which was -36.10% lower than expectations of $0.97.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 10 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EHC is Hold with a score of 4.90. A total of 10 analysts rated the stock as Buy while 0 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles